Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
The emergence of Plasmodium falciparum parasites resistant to artemisinins compromises the efficacy of Artemisinin Combination Therapies (ACTs), the global first-line malaria treatment. Artemisinin resistance is a complex genetic trait in which nonsynonymous SNPs in PfK13 cooperate with other geneti...
Principais autores: | Nayak, S, Peto, TJ, Kucharski, M, Tripura, R, Callery, JJ, Quang Huy, DT, Gendrot, M, Lek, D, Nghia, HDT, van der Pluijm, RW, Dong, N, Long, LT, Vongpromek, R, Rekol, H, Hoang Chau, N, Miotto, O, Mukaka, M, Dhorda, M, von Seidlein, L, Imwong, M, Roca, X, Day, NPJ, White, NJ, Dondorp, AM |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Nature Research
2024
|
Registros relacionados
-
Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
por: Nayak, Sourav, et al.
Publicado em: (2025) -
Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
por: Sourav Nayak, et al.
Publicado em: (2024-12-01) -
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
por: Peto, TJ, et al.
Publicado em: (2022) -
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
por: van der Pluijm, RW, et al.
Publicado em: (2022) -
Triple artemisinin-based combination therapies for malaria – a new paradigm?
por: van der Pluijm, RW, et al.
Publicado em: (2020)